Records containing: Progressive Supranuclear Palsy (PSP)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-10
Molecular Imaging of Synaptic Loss in Multiple System Atrophy (MSA)
CLINICAL_TRIALS study record update · 2026-01-16
First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands ([18F]ABBV964i and [ 18F]ABBV-965i) as Potential PET Radioligands for Imaging Tau Protein in the Brain of Patients With Probable PSP and Healthy Volunteers
CLINICAL_TRIALS study record update · 2026-01-14
The CurePSP Genetics Program
CLINICAL_TRIALS study record update · 2025-12-24
A Randomized, Participant, Investigator and Sponsor Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intrathecally Administered NIO752 in Participants With Progressive Supranuclear Palsy
CLINICAL_TRIALS study record update · 2025-08-22
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-07-11
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
CLINICAL_TRIALS study record update · 2025-04-13
The Four-Repeat Tauopathy Neuroimaging Initiative
CLINICAL_TRIALS study record update · 2024-09-19
A Multi-centre Proof-of-performance Clinical Study to Validate Blood-based Biomarker Candidates for the Diagnosis of Alzheimer's Disease
CLINICAL_TRIALS study record update · 2023-10-16
A Multicentre, Phase 3, Clinical Study to Compare the Striatal Uptake of a Dopamine Transporter Radioligand, DaTSCAN™ Ioflupane (123I) Injection, After Intravenous Administration to Chinese Patients With a Diagnosis of Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy, or Essential Tremor and to Healthy Controls
CLINICAL_TRIALS study record update · 2023-07-20
RIVA-PSP: Efficacy of Rivastigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy: A Randomised Double Blind Placebo-controlled Clinical Trial
CLINICAL_TRIALS study record update · 2022-04-13
Human CNS Tau Kinetics in Tauopathies
CLINICAL_TRIALS study record update · 2021-05-21
Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2
CLINICAL_TRIALS study record update · 2021-02-03
An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)
CLINICAL_TRIALS study record update · 2020-10-19
PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
CLINICAL_TRIALS study record update · 2020-04-15
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI 287 in Patients With Primary Four Repeat Tauopathies: Corticobasal Syndrome or Progressive Supranuclear Palsy
CLINICAL_TRIALS study record update · 2020-01-03
Multimodal MRI Markers of Nigrostriatal Pathology in Parkinson's Disease
CLINICAL_TRIALS study record update · 2019-12-03
Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104
CLINICAL_TRIALS study record update · 2016-12-16
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Clinically Diagnosed Tauopathies in Comparison to Healthy Subjects
CLINICAL_TRIALS study record update · 2016-12-16
Phase 0 Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Alzheimer's Disease and Other Tauopathies